Share on LinkedInShare on LinkedIn

ARTICLE · 30 DECEMBER 2021

Market Intelligence Thought Leadership Award Winner

COVID-19 Vaccine Patent Discussions

Discussions of world leaders about the abolishing of intellectual property rights of covid-19 vaccines have brought along differences of opinion on this issue.

TurkeyIntellectual Property

Discussions of world leaders about the abolishing of intellectual property rights of covid-19 vaccines have brought along differences of opinion on this issue. The world is currently debating whether removing vaccine patent rights will actually work in the fight against the corona pandemic or hinder the development and production of vaccines that are vital to humanity.

While America and Russia are in favor of abolishing these rights, Europe argues that the problem of the unequal distribution of vaccines all over the world cannot be solved by abolishing the patent right of vaccines.

People who take side to the abolition of vaccine patent rights argue that vaccine manufacturers should transfer their know-how and technologies, in favor of easier access to drugs and a special arrangement that allows the suspension of patent rights. Pharmaceutical companies state that the suspension of patent rights will not increase the supply of vaccines in the short term.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from